This article by Applied Clinical Trials explores BioAgilytix’s new customizable COVID-19 testing packages that include services to address sponsor needs stemming from the coronavirus pandemic.
WRAL TechWire lists BioAgilytix’s new COVID-19 testing packages as noteworthy technology news affecting the North Carolina ecosystem.
This article by Verdict Medical Devices explores BioAgilytix’s new customizable COVID-19 testing packages, which include return-to-work screening for employers and assays for clinical sponsors.
The Business Wire covers the launch of BioAgilytix’s customizable COVID-19 testing packages, which include services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
3rd Watch News lists BioAgilytix as a top, key player in its “COVID-19 Impact on Global Cell-based Assays Market Size, Status and Forecast 2020-2026.”
The Derrick explores BioAgilytix’s new customizable COVID-19 testing packages with services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
PRNewswire covers BioAgilytix’s listing on The “Bioanalytical Testing Services Market by Type, Application, End User – Global Forecasts to 2025 ” report that was added to ResearchAndMarkets.com’s offering.
In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.
The Triangle Business Journal covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the Cambridge area of Massachusetts, a known hotbed of biotech innovation.
Contract Pharma covers BioAgilytix’s recent acquisition of Cambridge Biomedical, a CRO specializing in large molecule bioanalysis based in the biotech hub of Boston, MA.
Services
Platforms